Roswell Park researchers identify protein that contributes to racial disparities in prostate cancer

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print

Cancer researchers have long known that prostate cancer tends to be more common, more aggressive and more resistant to existing treatments in African Americans than in Caucasian Americans, but they’re only beginning to understand why.

To access this subscriber-only content please log in or subscribe.

If your institution has a site license, log in with IP-login or register for a sponsored account.*
*Not all site licenses are enrolled in sponsored accounts.

Login Subscribe
Table of Contents

YOU MAY BE INTERESTED IN

Throughout my career as a physician and scientist, I’ve seen ideas once considered impossible become breakthroughs that save lives. They happened because talented scientists had the resources, institutions, and sustained support to pursue ambitious ideas. Most importantly, they knew patients could not afford to wait. 

Never miss an issue!

Get alerts for our award-winning coverage in your inbox.

Login